Punglim Pharmatech Mass Produces Vaccine Syringes with 'Minimal Residual Volume'... Supported by Ministry of SMEs and Samsung Electronics

Mass Production of Vaccine Syringes Applying Minimum Dose Syringe (LDS 4μL) Technology
Establishment of a Production System for Syringes Capable of Administering 6 Doses per Vaccine Vial (Compared to 5 Doses with Conventional Syringes)

Minister Park Young-sun of the Ministry of SMEs and Startups is announcing the detailed plan for the execution of the Support Fund on the 12th at the Government Seoul Office in Jongno-gu, Seoul. Photo by Kang Jin-hyung aymsdream@

[Asia Economy Reporter Kim Heeyoon] The Ministry of SMEs and Startups announced on the 19th that medical device SME Poonglim Pharmatech has established a mass production system for syringes used for the rapidly increasing demand for COVID-19 vaccines, thanks to the win-win smart factory support from the Ministry and Samsung Electronics.

Poonglim Pharmatech has built a smart factory mass production system capable of producing more than 10 million COVID-19 vaccine syringes per month, applying the highest-level Low Dead Space (LDS) 4μL technology. The Poonglim LDS syringe is characterized by significantly reducing residual volume loss. While a general syringe can only inject up to 5 doses per vial of COVID-19 vaccine, the Poonglim LDS syringe can inject 6 or more doses per vial, effectively increasing COVID-19 vaccine output by 20% compared to general syringes.

Major COVID-19 vaccine pharmaceutical companies in the US, EU, and other regions package vaccine syringes along with vaccines and require a minimum dead space performance of 25μL or less and a safe guard function to prevent infection spread during injection to maximize the supply of vaccine syringes relative to vaccine production volume.

The Poonglim LDS syringe meets the performance requirements of COVID-19 vaccine pharmaceutical companies, passing performance tests such as minimum dead space by US pharmaceutical companies. It has filed domestic technology and design patents related to minimum dead space and safe guard functions and is also pursuing international patents in the US, EU, and other regions.

In this regard, Poonglim Pharmatech received domestic usage approval from the Ministry of Food and Drug Safety for vaccine syringes (LDS performance), safe guard, and needles on the 6th and 15th respectively.

The Ministry of SMEs and Startups quickly deployed SME support programs such as the win-win smart factory with Samsung Electronics to help our excellent technology SMEs utilize opportunities to enter the global market. Since the end of last month, Samsung Electronics has deployed about 30 experts and completed prototype mold production and prototype manufacturing in just 4 days during the year-end holidays through Samsung Electronics’ partner factories in Gumi and Gwangju. This has led to visible results such as completing the smart factory production line including prototype production and mass production facility construction within just one month.

Minister Park Young-sun of the Ministry of SMEs and Startups emphasized regarding the mass production system establishment of Poonglim LDS syringes, "This is a representative successful model of public-private cooperation actively supported by the government, combining the excellent technology of our SMEs with the smart manufacturing know-how and global network capabilities of large corporations."